ISIN | LU0969575645 |
---|---|
Valor Number | 22479883 |
Bloomberg Global ID | VARI3US LX |
Fund Name | Variopartner SICAV - MIV Global Medtech Fund I3 |
Fund Provider |
MIV Global Medtech Fund
Feldeggstrasse 55 8008 Zürich Schweiz Phone: +41 44 253 64 11 E-Mail: info@mivam.ch |
Fund Provider | MIV Global Medtech Fund |
Representative in Switzerland |
Vontobel Fonds Services AG Zürich Phone: +41 58 283 74 77 |
Distributor(s) |
Vontobel Fonds Services AG Zürich Phone: +41 58 283 74 77 |
Asset Class | Equities |
EFC Category | Equity Health Care |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | This Sub-Fund aims to achieve maximum capital growth by means of investments in the sector of medical technology worldwide. In order to achieve this, and taking account of the principle of risk diversification, a minimum of two-thirds of the SubFund’s total assets are invested directly in equities, equity-like transferable securities, participation certificates, depositary receipts, such as American Depositary Receipts (ADRs), Global Depositary Receipts (GDRs) and European Depositary Receipts (EDRs) referring to such securities, etc. from issuers worldwide, mainly active in the sector of medical technology. Besides this, up to one third of the total assets of the Sub-Fund may be invested in participation securities from companies that are not or not principally active in the sector of medical technology. |
Peculiarities |
Current Price * | 3,165.64 USD | 02.09.2025 |
---|---|---|
Previous Price * | 3,190.88 USD | 29.08.2025 |
52 Week High * | 3,312.55 USD | 05.02.2025 |
52 Week Low * | 2,800.57 USD | 08.04.2025 |
NAV * | 3,165.64 USD | 02.09.2025 |
Issue Price * | 3,165.64 USD | 02.09.2025 |
Redemption Price * | 3,165.64 USD | 02.09.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 1,976,792,140 | |
Unit/Share Assets *** | 313,313,176 | |
Trading Information SIX |
YTD Performance | +5.36% |
31.12.2024 - 02.09.2025
31.12.2024 02.09.2025 |
---|---|---|
YTD Performance (in CHF) | -6.63% |
31.12.2024 - 02.09.2025
31.12.2024 02.09.2025 |
1 month | +0.66% |
04.08.2025 - 02.09.2025
04.08.2025 02.09.2025 |
3 months | +1.28% |
02.06.2025 - 02.09.2025
02.06.2025 02.09.2025 |
6 months | -3.23% |
03.03.2025 - 02.09.2025
03.03.2025 02.09.2025 |
1 year | +2.79% |
03.09.2024 - 02.09.2025
03.09.2024 02.09.2025 |
2 years | +20.20% |
05.09.2023 - 02.09.2025
05.09.2023 02.09.2025 |
3 years | +31.88% |
02.09.2022 - 02.09.2025
02.09.2022 02.09.2025 |
5 years | +15.55% |
02.09.2020 - 02.09.2025
02.09.2020 02.09.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 0.8028 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 02.09.2025 |
Boston Scientific Corp | 9.95% | |
---|---|---|
Stryker Corp | 9.94% | |
Abbott Laboratories | 9.73% | |
Intuitive Surgical Inc | 9.14% | |
Essilorluxottica | 4.99% | |
Medtronic PLC | 4.95% | |
Edwards Lifesciences Corp | 4.19% | |
Becton Dickinson & Co | 4.02% | |
ResMed Inc | 3.68% | |
IDEXX Laboratories Inc | 3.48% | |
Last data update | 31.07.2025 |
TER | 0.96% |
---|---|
TER date | 31.12.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.90% |
Ongoing Charges *** | 0.96% |
SRRI ***
|
|
SRRI date *** | 31.07.2025 |